Region Stockholm – SLSO

6 trials 1 recruiting Academic / non-commercial

Filter these 6 trials by condition, phase, country and more.

Open in Search →
6 Registered trials
1 Recruiting
0 Completed trials
1 Countries active
10 Unique IMPs
N/A Results reported
Phase III: 2 Phase II: 3 Phase IV: 1
Oversight events:
1 temporary halt across 1 trial
View oversight register →

Top indications

Multiple sclerosis relapse prophylaxis 1 Tick-borne viral encephalitis 1 Relapsing multiple sclerosis 1

Top IMPs

(4R)-1-[(3-(11C)METHYLPYRIDIN-4-YL)METHYL]-4-(3,4,5-TRIFLUOROPHENYL)PYRROLIDIN-2-ONE 1 CETIRIZINE DIHYDROCHLORIDE 1 EXENATIDE 1 INFLUENZA VIRUS B/MICHIGAN/01/2021, INFLUENZA A/VICTORIA/4897/2022 IVR-238 (H1N1), INACTIVATED, INFLUENZA A VIRUS, A/CROATIA/10136RV/2023 (H3N2) LIKE STRAIN X-425A, INACTIVATED 1 METHYLPREDNISOLONE 1 PARACETAMOL 1 PSILOCYBINE 1 TOLEBRUTINIB 1

All trials

6 total

Showing 1–6 of 6 trials

← All sponsors A–Z